InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by JANNEY DANIEL, Director. Insider active across 2 companies, notably Esperion Therapeutics, Inc.. Cumulatively, 4 filings have been published. Total volume traded: €12.5m. The latest transaction was filed on 10 December 2021 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€6m100,000 shares@ €62.42630.087% mcap100.0% of flow
Common Stock
SEC:0000899243-21-048122·
€6m100,000 shares@ €62.42630.087% mcap50.0% of flow
Common Stock
SEC:0000899243-21-048122:0·
012,376 shares0
Common Stock
SEC:0001628280-21-011356·
012,376 shares0
Common Stock
SEC:0001628280-21-011356:0·
4 of 4 declarations
About JANNEY DANIEL
Daniel Janney serves as a Director at Esperion Therapeutics, Inc. and Krystal Biotech, Inc. In this role, he contributes to the strategy and governance of the companies. His expertise in the biopharmaceutical sector is an asset to the board.
